These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 1211920
1. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic. Shemonsky NK, Carrizosa J, Levison ME. Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920 [Abstract] [Full Text] [Related]
2. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Eykyn S, Jenkins C, King A, Phillips I. Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616 [Abstract] [Full Text] [Related]
3. Cefamandole: in vitro and clinical pharmacokinetics. Griffith RS, Black HR, Brier GL, Wolny JD. Antimicrob Agents Chemother; 1976 Nov; 10(5):814-23. PubMed ID: 1008540 [Abstract] [Full Text] [Related]
4. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates. Jones RN, Fuchs PC. Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021 [Abstract] [Full Text] [Related]
12. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Eickhoff TC, Ehret JM. Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029 [Abstract] [Full Text] [Related]
13. Clinical pharmacology of cefamandole as compared with cephalothin. Fong IW, Ralph ED, Engelking ER, Kirby WM. Antimicrob Agents Chemother; 1976 Jan; 9(1):65-9. PubMed ID: 1259393 [Abstract] [Full Text] [Related]
14. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model. Randolph JA, Buck RE, Price KE, Leitner F. J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292 [Abstract] [Full Text] [Related]
15. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile. Ratzan KR, Baker HB, Lauredo I. Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864 [Abstract] [Full Text] [Related]
16. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Eykyn S, Jenkins C, King A, Phillips I. Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441 [Abstract] [Full Text] [Related]
17. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides. Fu KP, Neu HC. J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097 [Abstract] [Full Text] [Related]
18. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole. Greenberg RN, Bollinger M. Clin Ther; 1985 May; 7(2):151-3. PubMed ID: 3886140 [Abstract] [Full Text] [Related]
19. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. Uete T, Matsuo K. Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453 [Abstract] [Full Text] [Related]
20. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae. Barry AL, Jones RN, Thornsberry C. Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]